Qualitative experiences and depression/ anxiety scores in parents of
children with Cystic Fibrosis Transmembrane Related Metabolic Syndrome
Abstract
Cystic Fibrosis Transmembrane Related Metabolic Syndrome/Cystic Fibrosis
Screen Positive, Inconclusive Diagnosis describes children with a
positive newborn screen for whom follow-up tests do not confirm CF. Many
are healthy carriers, but some will convert to a CF diagnosis; the
natural history is not yet well understood. In children with chronic
illnesses, unpredictable disease process and limited knowledge of
long-term consequences present significant challenges to parental mental
health. We wanted to understand the emotional wellbeing of parents with
children with CRMS/CFSPID to guide the mental health support offered
within the service. Parents were invited to complete validated
depression and anxiety screening questionnaires and a short interview.
Interview responses were transcribed and analysed using thematic
analysis. Thirteen parents from 10 families completed questionnaires
and/or the interview. Two of the parents had raised scores on the
questionnaires. Our interviews revealed five themes explored here:
difficulty adjusting to the label; concern about the future and its
uncertainty; fluctuating states of anxiety (subthemes linked to
respiratory tract infections and to medical appointments); difficulty
explaining the label (subthemes to healthcare professionals and
non-healthcare professionals); and satisfaction with the CRMS/CFSPID
service. Our data reveal relatively benign scores using objective
screening tools, but the qualitative data paints a picture of
significant impact on wellbeing. We recommend screening parents from the
time their child receives the label, and later the children themselves,
for depression and anxiety and signposting to existing resources.
Ultimately, a better understanding of the CRMS/CFSPID trajectory may
enable us to give families the answers they need.